Pharmacologic Targeting of MMP2/9 Decreases Peritoneal Metastasis Formation of Colorectal Cancer in a Human Ex Vivo Peritoneum Culture Model
J. Koch(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Philipp Renner(Robert Bosch Hospital)
Cited by 9
Related Papers
Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate
|Transplant Immunology|2008|198
Urinary Biomarkers TIMP-2 and IGFBP7 Early Predict Acute Kidney Injury after Major Surgery
|PLoS ONE|2015|168